News Detail
New Delhi, 16 May 2023: The Union health ministry is planning to amend the New Drugs and Clinical Trials Rules (NDCTR), 2019 to define clinical research organisations (CROs) and to lay down rules for registration, inspection and renewal of registration for these organisations.
Source : Pharmabiz
Union health ministry
NDCTR
2019
CROs
rules for registration
Central Licensing Authority
CLA
Chapter V
BA/BE studies
health news
drugscontrol
drugscontrol news
drugs and cosmetics act 1940
drugs rules 1945
 health news
advertising
health news
drugscontrol
drugscontrol news
drugs and cosmetics act 1940
drugs rules 1945
Banned drugs in India
Schedule M
schedule dÂ
Related News
- Zydus gets warning as FDA highlights glass contamination concerns and others (12-09-2024)
- MPIDC allotted land to 36 industries in Medical Devices Park, investment of 1.8k crore (12-09-2024)
- DCC asks states and UTs to ensure implementation of revised Schedule M (12-09-2024)
- NPPA fixes retail price of 62 new drugs, extends CP of knee implants (12-09-2024)
- US FDA Issues Revised Guidance On Controlling Nitrosamine Impurities In Pharmaceuticals (12-09-2024)
- Bharat Biotech collaborates with US-based Alopexx to develop antimicrobial vaccine (12-09-2024)
- DCGI suspends permission to Entod pharma's 'Presvu Eye Drops', company to challenge order in court (11-09-2024)
- Diagnostic kits for early detection of Alzheimer’s and cancer launched (11-09-2024)
- FDI equity inflow into pharma sector grows to $236 million in Q1FY25 (11-09-2024)
- Steroid Use Could Raise Diabetes Risk (11-09-2024)